Biotech

All Articles

Cullinan, after $25M deal, return bispecific to Harbour

.Cullinan Therapy was blown away sufficient along with Harbour BioMed's bispecific immune reactor th...

A better consider Brutal Biotech's Tough 15

.In this particular week's episode of "The Best Line," our team're diving in to Tough Biotech's annu...

Lilly faces phase 2 failure of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's gathering celebrating the approval o...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings a...

Lykos are going to ask FDA to reevaluate its choice observing rejection of MDMA therapy for trauma

.Complying with a bad presenting for Lykos Therapies' MDMA candidate for trauma at a latest FDA cons...

AN 2 halves head count, stops period 3 test after information let down

.AN2 Therapeutics is reconsidering its service in response to uninspired midphase records, pledging ...

Merck spends $700M for bispecific, snooping autoimmune opening and also chance to test Amgen in cancer

.Merck &amp Co. is actually spending $700 thousand upfront to challenge Amgen in a blood stream canc...

Gilead spends J&ampJ $320M to exit licensing deal for seladelpar

.Along With Gilead Sciences almost an FDA choice for its own liver disease medication seladelpar, th...

' All palms on deck' at Lilly as peers target obesity market

.CEO David Ricks can easily find the providers establishing outdoors tents at basecamp responsible f...

Entero laying off personnel, moving out of workplace and also stopping briefly R&ampD

.Cushion Liquidators has transformed Entero Therapies white as a slab. The financial institution bou...